Contents of this document
- Capital and business alliance with the Seibu Group and development of a dog-outing ecosystem
- Expand the number of SKUs covered by the subscription service from 1,700 to 5,500
- Expand the veterinary hospital channel for therapeutic diets, flea treatments and tick treatments
- Development and planned launch of new wet products
- Development and planned launch of new premium foods
- Redesign CRM, improve UI/UX, and enhance recommendation accuracy
- DTC revenue mix37 %Year on year against the same period last year+4.0%
- Subscription commerce revenue¥425 millionYear on year against the same period last year+112.0%
- Subscription commerce revenue as a percentage of DTC revenue45 %Year on year against the same period last year+2.0%
- Active purchasers44 10,000 peopleYear on year against the same period last year+88.0%
- Cumulative unique purchasers280 10,000 peopleYear on year against the same period last year+106.0%
- Event attendees8 10,000 people
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | First quarter of the fiscal year ending March 2027 |
| Net Sales | ¥1,651 million (YoY +84.0%) |
| Operating profit | ¥-8 million |
| Operating profit margin | -0.5 % |
| Selling, general and administrative expenses | ¥547 million |
| Results for the three months of the current quarter | Company-wide revenue ¥1,651 million / Operating profit ¥-8 million / Operating profit margin -0.5 % / EBITDA ¥9 million / NB revenue ¥1,005 million / DTC revenue ¥584 million |
| Full-year earnings forecast | Company-wide revenue ¥7,992 million / NB revenue ¥4,863 million / DTC revenue ¥3,027 million / Operating profit ¥153 million / Operating profit margin 1.9 % |
| Segment results | Pet Commerce Business Net Sales ¥1,546 million / Year-on-year change in revenue 82 / Segment profit ¥55 million / Segment profit, year on year 192 / Pet Media Business Net Sales ¥102 million / Year-on-year change in revenue 132 / Segment profit ¥36 million / Segment profit, year on year 131 |
| Breakdown of Factors Affecting the Change | Selling, general and administrative expenses Variable costs Change in amount ¥-52 million / Strategic Investment Change in amount ¥-42 million / Other fixed costs Change in amount ¥17 million / Breakdown of strategic investment Advertising spend Change in amount ¥-35 million / Promotional expenses Change in amount ¥-6 million / Research and development costs Change in amount ¥0 million / Coupons and points Change in amount ¥-19 million |
| Key KPIs | Indicator name DTC revenue mix / Value 37 % / Year on year against the same period last year 4 %, Indicator name Subscription commerce revenue / Value ¥425 million / Year on year against the same period last year ¥112 million, Indicator name Subscription commerce revenue as a percentage of DTC revenue / Value 45 % / Year on year against the same period last year 2 %, Indicator name Active purchasers / Value 44 10,000 people / Year on year against the same period last year 88 10,000 people, Indicator name Cumulative unique purchasers / Value 280 10,000 people / Year on year against the same period last year 106 10,000 people, Indicator name Event attendees / Value 8 10,000 people / Year on year against the same period last year Not disclosed |
| Number of employees | Number of Employees 57 people / As of As of the end of June 2026 |
| Medium-term management plan targets | Market capitalization 100 Hundreds of millions of yen / Roadmap Short term Fiscal year ending March 2027 / Medium term FY2028-FY2029 / Longer term FY2030 onward |
| Market Size / Share | Dog-outing market size 4,000 Billions of yen / Global Pawprint Economy 5,000 Over $10 billion through 2030 |
| New initiatives | Capital and business alliance with the Seibu Group and development of a dog-outing ecosystem, Expand the number of SKUs covered by the subscription service from 1,700 to 5,500, Expand the veterinary hospital channel for therapeutic diets, flea treatments and tick treatments, Development and planned launch of new wet products, Development and planned launch of new premium foods, Redesign CRM, improve UI/UX, and enhance recommendation accuracy |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.NB sales declined due to the post-surge decline in Royal Canin therapeutic diets, while DTC sales fell as advertising and promotional investment was controlled. Meanwhile, the shift toward DTC improved the profit structure, restrained strategic investment, and the hosting of major events contributed to profit and growth in the Pet Media Business.